The Debt to Equity Ratio is a company’s total liabilities divided by its shareholder equity. It's the degree to which a company is financing its operations through debt v/s wholly owned funds

Lower than Industry Debt to Equity Ratio

Current ratio measures a company’s ability to pay short-term obligations. Higher is better

Lower than Industry Current Ratio

The EBITDA margin is the percent of revenue that the company retains after incurring all the direct and operational costs of the business

Lower than Industry EBITDA Margin

The net profit margin is net income or profit generated as a percentage of revenue and illustrates how much of each rupee in revenue translates to profit

Lower than Industry Net Profit Margin

Y-o-y growth in the total revenue represents increased potential for the company to increase their market share.Total revenue for the current quarter is compared with the same quarter of previous year to reduce the effects of seasonality

Increasing Total Revenue

Y-o-y growth in the net income represents increased profitability of the company.Net profit for the current quarter is compared with the same quarter of previous year to reduce the effects of seasonality

Increasing Net Profit

Increasing EBITDA margin indicates increased profit efficiency without taking into account financial, accounting or tax implications

Increasing EBITDA Margin

Increasing Net profit margins indicates the increasing profit to the shareholders with each unit of revenue

Increasing Net Profit Margin

Y-o-y growth in the EBITDA represents how efficiently the company manages its expenses.EBITDA for the current quarter is compared with the same quarter of previous year to reduce the effects of seasonality

Increasing EBIDTA

Jubilant Ingrevia Limited has informed the Exchange about Investor Presentation

Investor Presentation

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the management of the Company shall be participating in Axis Capital India Chemicals Conference 2022 Virtual Investor Conference on Tuesday March 29 2022. We enclose names of the Investors/Analysts participating in the same.The schedule may undergo change due to exigencies on the part of Investors/ Analysts/Company.We also enclose the presentation to be used during the e-conference.This is for your information and record.

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be  participating in ￢ﾀﾘEdelweiss India Conference, 2022, Singapore￢ﾀﾙ physical Investor meetings to be held on Thursday, August 18, 2022 and Friday, August 19, 2022 in Singapore. The details of the Investors are mentioned in the Intimation Letter. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/Company. This is for your information and records.

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be meeting the following Institutional Investors in Mumbai on Wednesday, November 09, 2022 & Thursday, November 10, 2022. The details of the Investors/Analysts are mentioned in the Intimation Letter.

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Jubilant Ingrevia is engaged in the business of integrated life science products.

Jubilant Ingrevia Ltd

Jubilant Ingrevia Ltd

Scorecard

Financial Statements

What is an income statement?

Income Statement

Company Updates